ticlopidine has been researched along with Degos Disease in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slaviero, F | 1 |
| Annes, RD | 1 |
| Frighetto, L | 1 |
| Schirmer, LM | 1 |
| Vanzin, JR | 1 |
| Fröhlich, AC | 1 |
| Ferraz, J | 1 |
| Azambuja, ND | 1 |
1 other study available for ticlopidine and Degos Disease
| Article | Year |
|---|---|
Köhlmeier-Degos Disease (malignant atrophic papulosis) and neurologic involvement.
Topics: Adult; Aspirin; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Malignant Atrophic Papulosis; T | 2009 |